REFERENCES
  1. Mlambo NE, Dlamini NNM, Urry RJ. Correlation between radiological and histopathological findings in patients undergoing nephrectomy for presumed renal cell carcinoma on computed tomography scan at Grey’s Hospital. SA J Radiol 2018; 22(1): 1339.
  2. Ljungberg B, Albiges L, Abu-Ghanem Y, Bensalah K, Dabestani S, Fernández-Pello S, Giles RH, Hofmann F, Hora M, Kuczyk MA, Kuusk T, Lam TB, Marconi L, Merseburger AS, Powles T, Staehler M, Tahbaz R, Volpe A, Bex A. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update. Eur Urol 2019; 75(5): 799-810.
  3. Türkvatan A, Akdur PO, Altinel M, Olçer T, Turhan N, Cumhur T, Akinci S, Ozkul F. Preoperative staging of renal cell carcinoma with multidetector CT. Diagn Interv Radiol 2009; 15(1): 22-30.
  4. Sheth S, Scatarige JC, Horton KM, Corl FM, Fishman EK. Current concepts in the diagnosis and management of renal cell carcinoma: role of multidetector ct and three-dimensional CT. Radiographics 2001; 21: 237-54.
  5. Srivastava A, Patel HD, Joice GA, Semerjian A, Gorin MA, Johnson MH, Allaf ME, Pierorazio PM. Incidence of T3a up-staging and survival after partial nephrectomy: Size-stratified rates and implications for prognosis. Urol Oncol 2018; 36(1): 12.e7-12.e13.
  6. Lee H, Lee M, Lee SE, Byun SS, Kim HH, Kwak C, Hong SK. Outcomes of pathologic stage T3a renal cell carcinoma up-staged from small renal tumor: emphasis on partial nephrectomy. BMC Cancer 2018; 18(1): 427.
  7. PA Harris, R Taylor, R Thielke, J Payne, N Gonzalez, JG. Conde, Research electronic data capture (REDCap) – A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42(2): 377-81.
  8. PA Harris, R Taylor, BL Minor, V Elliott, M Fernandez, L O’Neal, L McLeod, G Delacqua, F Delacqua, J Kirby, SN Duda, REDCap Consortium, The REDCap consortium: Building an international community of software partners. J Biomed Inform 2019 May 9 [doi: 10.1016/j.jbi.2019.103208]
  9. Munoz S, Bangdiwala S: Interpretation of kappa and B statistics measures of agreement. J Appl Statistics 1997;24:105–111.
  10. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D, Bray F. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013; 49(6): 1374-403.
  11. Novara G, Ficarra V, Antonelli A, Artibani W, Bertini R, Carini M, Cosciani Cunico S, Imbimbo C, Longo N, Martignoni G, Martorana G, Minervini A, Mirone V, Montorsi F, Schiavina R, Simeone C, Serni S, Simonato A, Siracusano S, Volpe A, Carmignani G; SATURN Project-LUNA Foundation. Validation of the 2009 TNM version in a large multi-institutional cohort of patients treated for renal cell carcinoma: are further improvements needed? Eur Urol 2010; 58(4): 588-95.
  12. Catalano C, Fraioli F, Laghi A, Napoli A, Pediconi F, Danti M, Nardis P, Passariello R. High-resolution multidetector CT in the preoperative evaluation of patients with renal cell carcinoma. AJR Am J Roentgenol 2003; 180(5): 1271-7.
  13. Yoon J, Herts BR. Staging renal cell carcinoma with helical CT: the revised 1997 AJCC and UICC TNM criteria. Crit Rev Comput Tomogr 2003; 44(4): 229-49.
  14. Coll DM, Smith RC. Update on radiological imaging of renal cell carcinoma. BJU Int 2007; 99(5 Pt B): 1217-22.
  15. Renard AS, Nedelcu C, Paisant A, Saulnier P, Le Bigot J, Azzouzi AR, Bigot P, Aubé C.Is multidetector CT-scan able to detect T3a renal tumor before surgery? Scand J Urol 2019; 53(5): 350-355.
  16. Chevinsky M, Imnadze M, Sankin A, Winer A, Mano R, Jakubowski C, et al. Pathological stage T3a significantly increases disease recurrence across all tumor sizes in renal cell carcinoma. J Urol 2015;194: 310–5.
  17. Park M, Shim M, Kim M, Song C, Kim C, Ahn H. Prognostic heterogeneity in T3aN0M0 renal cell carcinoma according to the site of invasion. Urol Oncol, 35 (7), 458.
  18. Wu Y, Kwon YS, Labib M, Foran DJ, Singer ES. Magnetic resonance imaging as a biomarker for renal cell carcinoma. Disease Markers 2015; 2015: 1-9.
  19. Bansal RK, Tanguay S, Finelli A, Rendon R, Moore RB, Breau RH, Lacombe L, Black PC, Kawakami J, Drachenberg D, Pautler S, Saarela O, Liu Z, Jewett MAS,Kapoor A. Positive surgical margins during partial nephrectomy for renal cell carcinoma: Results from Canadian Kidney Cancer information system (CKCis) collaborative. Can Urol Assoc J 2017; 11(6): 182-7.
  20. Ani I, Finelli A, Alibhai SM, Timilshina N, Fleshner N, Abouassaly R. Prevalence and impact on survival of positive surgical margins in partial nephrectomy for renal cell carcinoma: a population-based study. BJU Int 2013; 111(8): 1-5.